{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:38:29Z","timestamp":1762979909563,"version":"3.45.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001858","name":"VINNOVA","doi-asserted-by":"publisher","award":["2015-0180"],"award-info":[{"award-number":["2015-0180"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Open Science"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.euros.2020.11.001","type":"journal-article","created":{"date-parts":[[2020,11,27]],"date-time":"2020-11-27T19:02:54Z","timestamp":1606503774000},"page":"88-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography\/Computed Tomography Examination"],"prefix":"10.1016","volume":"22","author":[{"given":"Thomas","family":"Papathomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7563-732X","authenticated-orcid":false,"given":"Antonios","family":"Tzortzakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Erlmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Feuchtinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiril","family":"Trpkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Bazarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandros","family":"Arvanitis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bela","family":"Bozoky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia","family":"Kokaraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimma","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Walch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euros.2020.11.001_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/KCA-170008","article-title":"Molecular classification of renal cell carcinoma and its implication in future clinical practice","volume":"1","author":"Casuscelli","year":"2017","journal-title":"Kidney Cancer"},{"key":"10.1016\/j.euros.2020.11.001_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.06.032","article-title":"The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.euros.2020.11.001_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.03.077","article-title":"Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers","volume":"23","author":"Peng","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.euros.2020.11.001_bib0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eururo.2015.08.056","article-title":"Prospective evaluation of 99mTc-sestamibi SPECT\/CT for the diagnosis of renal oncocytomas and hybrid oncocytic\/chromophobe tumors","volume":"69","author":"Gorin","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2020.11.001_bib0025","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13550-017-0329-5","article-title":"Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression","volume":"7","author":"Rowe","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0030","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13550-017-0277-0","article-title":"Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality?","volume":"7","author":"Rowe","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13550-017-0278-z","article-title":"Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT\/CT","volume":"7","author":"Tzortzakakis","year":"2017","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2967\/jnmt.118.223297","article-title":"Intra- and interobserver agreement of SUV SPECT quantitative SPECT\/CT processing software, applied in clinical settings for patients with solid renal tumors","volume":"47","author":"Tzortzakakis","year":"2019","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.euros.2020.11.001_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00418-015-1324-4","article-title":"Supremacy of modern morphometry in typing renal oncocytoma and malignant look-alikes","volume":"144","author":"Erlmeier","year":"2015","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.euros.2020.11.001_bib0050","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/nprot.2016.081","article-title":"High-mass-resolution MALDI mass spectrometry imaging of metabolites from formalin-fixed paraffin-embedded tissue","volume":"11","author":"Ly","year":"2016","journal-title":"Nat Protoc"},{"key":"10.1016\/j.euros.2020.11.001_bib0055","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/nar\/gkl923","article-title":"HMDB: the Human Metabolome Database","volume":"35","author":"Wishart","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0060","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0065","first-page":"3316","article-title":"Comprehensive gene and pathway analysis of cervical cancer progression","volume":"19","author":"Yi","year":"2020","journal-title":"Oncol Lett"},{"key":"10.1016\/j.euros.2020.11.001_bib0070","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41379-019-0304-y","article-title":"Hybrid oncocytic\/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma","volume":"32","author":"Ruiz-Cordero","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.euros.2020.11.001_bib0075","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.euros.2020.11.001_bib0080","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euf.2018.01.016","article-title":"Metabolic and lipidomic reprogramming in renal cell carcinoma subtypes reflects regions of tumor origin","volume":"5","author":"Schaeffeler","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euros.2020.11.001_bib0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/path.4560","article-title":"High-resolution MALDI-FT-ICR MS imaging for the analysis of metabolites from formalin-fixed, paraffin-embedded clinical tissue samples","volume":"237","author":"Buck","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.euros.2020.11.001_bib0090","series-title":"R package version 2.0.0","article-title":"CARRoT: predicting categorical and continuous outcomes using one in ten rule","author":"Bazarova","year":"2019"},{"key":"10.1016\/j.euros.2020.11.001_bib0095","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ijc.32115","article-title":"Value of global metabolomics in association with diagnosis and clinicopathological factors of renal cell carcinoma","volume":"145","author":"Sato","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.euros.2020.11.001_bib0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bju.13763","article-title":"Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis","volume":"119","author":"Patel","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.euros.2020.11.001_bib0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.humpath.2017.03.004","article-title":"Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists","volume":"63","author":"Williamson","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euros.2020.11.001_bib0110","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00428-018-2456-4","article-title":"\u201cHigh-grade oncocytic renal tumor\u201d: morphologic, immunohistochemical, and molecular genetic study of 14 cases","volume":"473","author":"He","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euros.2020.11.001_bib0115","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1097\/PAS.0000000000000292","article-title":"Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2020.11.001_bib0120","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euros.2020.11.001_bib0125","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1710849115","article-title":"Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma","volume":"115","author":"Priolo","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euros.2020.11.001_bib0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours","volume":"70","author":"Moch","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euros.2020.11.001_bib0135","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00428-010-0898-4","article-title":"Sporadic hybrid oncocytic\/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases","volume":"456","author":"Petersson","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euros.2020.11.001_bib0140","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1158\/1078-0432.CCR-15-1217","article-title":"DNA methylation signature reveals cell ontogeny of renal cell carcinomas","volume":"22","author":"Malouf","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0145","first-page":"2255","article-title":"MALDI imaging on tissue microarrays identifies molecular features associated with renal cell cancer phenotype","volume":"34","author":"Steurer","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.euros.2020.11.001_bib0150","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1080\/14789450.2016.1248415","article-title":"The proteomic landscape of renal tumors","volume":"13","author":"Chinello","year":"2016","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.euros.2020.11.001_bib0155","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/metabo9080155","article-title":"Urinary metabolomics validates metabolic differentiation between renal cell carcinoma stages and reveals a unique metabolic profile for oncocytomas","volume":"9","author":"Falegan","year":"2019","journal-title":"Metabolites"},{"key":"10.1016\/j.euros.2020.11.001_bib0160","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euros.2020.11.001_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/path.4436","article-title":"De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry","volume":"235","author":"Balluff","year":"2015","journal-title":"J Pathol"}],"container-title":["European Urology Open Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168320363643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666168320363643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:05:36Z","timestamp":1762977936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666168320363643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":33,"alternative-id":["S2666168320363643"],"URL":"https:\/\/doi.org\/10.1016\/j.euros.2020.11.001","relation":{},"ISSN":["2666-1683"],"issn-type":[{"type":"print","value":"2666-1683"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography\/Computed Tomography Examination","name":"articletitle","label":"Article Title"},{"value":"European Urology Open Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euros.2020.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}